SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,427,550 | +92.9% | 307,000 | +241.2% | 0.34% | +48.3% |
| Q1 2022 | $740,000 | -92.7% | 89,980 | -86.8% | 0.23% | -89.3% |
| Q4 2021 | $10,118,000 | -0.4% | 680,000 | +26.4% | 2.15% | +13.1% |
| Q3 2021 | $10,159,000 | +10.0% | 537,800 | +8.2% | 1.90% | +23.7% |
| Q2 2021 | $9,237,000 | +18.7% | 496,900 | +45.3% | 1.53% | +34.2% |
| Q1 2021 | $7,783,000 | +11.3% | 341,950 | +6.1% | 1.14% | +25.1% |
| Q4 2020 | $6,995,000 | +376.8% | 322,200 | +120.7% | 0.91% | +218.5% |
| Q3 2020 | $1,467,000 | – | 146,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |